1. Home
  2. SNDX vs BLMN Comparison

SNDX vs BLMN Comparison

Compare SNDX & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • BLMN
  • Stock Information
  • Founded
  • SNDX 2005
  • BLMN 1988
  • Country
  • SNDX United States
  • BLMN United States
  • Employees
  • SNDX N/A
  • BLMN N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • BLMN Restaurants
  • Sector
  • SNDX Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • SNDX Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • SNDX 1.4B
  • BLMN 1.4B
  • IPO Year
  • SNDX 2016
  • BLMN 2012
  • Fundamental
  • Price
  • SNDX $13.69
  • BLMN $12.62
  • Analyst Decision
  • SNDX Strong Buy
  • BLMN Hold
  • Analyst Count
  • SNDX 11
  • BLMN 11
  • Target Price
  • SNDX $37.64
  • BLMN $18.00
  • AVG Volume (30 Days)
  • SNDX 1.9M
  • BLMN 1.7M
  • Earning Date
  • SNDX 11-05-2024
  • BLMN 11-08-2024
  • Dividend Yield
  • SNDX N/A
  • BLMN 7.62%
  • EPS Growth
  • SNDX N/A
  • BLMN N/A
  • EPS
  • SNDX N/A
  • BLMN N/A
  • Revenue
  • SNDX $16,000,000.00
  • BLMN $4,547,161,000.00
  • Revenue This Year
  • SNDX N/A
  • BLMN N/A
  • Revenue Next Year
  • SNDX N/A
  • BLMN N/A
  • P/E Ratio
  • SNDX N/A
  • BLMN N/A
  • Revenue Growth
  • SNDX N/A
  • BLMN N/A
  • 52 Week Low
  • SNDX $13.26
  • BLMN $12.18
  • 52 Week High
  • SNDX $25.34
  • BLMN $30.13
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 30.64
  • BLMN 40.40
  • Support Level
  • SNDX $13.36
  • BLMN $12.42
  • Resistance Level
  • SNDX $14.18
  • BLMN $13.09
  • Average True Range (ATR)
  • SNDX 0.81
  • BLMN 0.52
  • MACD
  • SNDX -0.18
  • BLMN 0.05
  • Stochastic Oscillator
  • SNDX 11.32
  • BLMN 15.22

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: